Sulfabenzamide
Names
[ CAS No. ]:
127-71-9
[ Name ]:
Sulfabenzamide
[Synonym ]:
Benzamide, N-[(4-aminophenyl)sulfonyl]-
N-[(4-Aminophenyl)sulfonyl]benzamide
N-(4-Aminobenzenesulfonyl)benzamide
4-Amino-N-benzoylbenzenesulfonamide
N-Benzoylsulfanilamide
Sulfabenzamide
N-(4-aminophenyl)sulfonylbenzamide
MFCD00044890
Sulfabenzamide(SB)
Sultrin
EINECS 204-859-4
Biological Activity
[Description]:
[Related Catalog]:
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.4±0.1 g/cm3
[ Melting Point ]:
180-184 °C
[ Molecular Formula ]:
C13H12N2O3S
[ Molecular Weight ]:
276.311
[ Exact Mass ]:
276.056854
[ PSA ]:
97.64000
[ LogP ]:
1.19
[ Index of Refraction ]:
1.636
[ Storage condition ]:
2-8°C
[ Water Solubility ]:
0.3 g/L (20 ºC)
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- CV5802500
- CHEMICAL NAME :
- Benzamide, N-sulfanilyl-
- CAS REGISTRY NUMBER :
- 127-71-9
- BEILSTEIN REFERENCE NO. :
- 2139003
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C13-H12-N2-O3-S
- MOLECULAR WEIGHT :
- 276.33
- WISWESSER LINE NOTATION :
- ZR DSWMVR
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 320 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#03348
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
N
[ Safety Phrases ]:
S22-S24/25
[ RIDADR ]:
3249
[ WGK Germany ]:
3
[ RTECS ]:
CV5802500
[ Packaging Group ]:
III
[ Hazard Class ]:
6.1(b)
[ HS Code ]:
2934999090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2924299090
[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles
J. Sci. Ind. Res. 65(10) , 808, (2006)
Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...
Developing structure-activity relationships for the prediction of hepatotoxicity.Chem. Res. Toxicol. 23 , 1215-22, (2010)
Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ...
A predictive ligand-based Bayesian model for human drug-induced liver injury.Drug Metab. Dispos. 38 , 2302-8, (2010)
Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti...